Markets continue to respond to macro concern as talks of banks de-levering and Federal Reserve intervention are on the radar for most participants. For example, providing liquidity and restoring confidence are areas of key interest among global central banks. Clearly, investor sentiment remains negative as volatility continues to rise and sentiment indicators are too bearish. From a mainstream perspective, market declines are attributed to discussions of economic concerns, rising commodity price pressures and mounting fear in the outlook ahead. In short, mean reversion in credit deterioration and commodity acceleration has not materialized.
Last week economic data failed to provide investors a positive catalyst. Not to mention the lingering effect of housing slowdown. Even oversold technical signals were not enough to spark a recovery in broad markets. Interestingly, the S&P 500 barely closed above its annual lows of 1270.05 reached on January 23, 2008. Perhaps, it is a bullish sign for a near-term recovery. Nonetheless, downtrend remains intact. This is showcased in Financials as the XLF (Amex Financial SPDR) has given up all its gains from 2004-2007. The index is 31% removed from its all-time lows reached in 2002. Therefore, there is room for downside move in the weakest group in this market correction. This reflects the trend shift in the business cycle as markets pause from multi-year bullish run.
There is a growing demand for cash rich companies with quality balance sheets, especially given weak returns. The current trend of declining yields, rising risk in small cap stocks and speculative commodity prices all contribute towards a favorable environment for "cash rich" stocks. For example, the
A long-term cycle perspective suggests that Large Cap is setting up for market leadership. Last year demonstrated early indication of relative strength in big cap themes. This rotation can present a sustainable upside move for 2-3 years. That said, selective approach is critical, this demonstrates attractiveness of companies in developed markets. Especially in themes related to innovation while having fundamental strength. Additional pessimism and investor selling of previous cycle winners can enhance demand for neglected and undervalued themes in US markets.
Stock Specific Ideas:
Healthcare:
GENZ (Genzyme): Consolidating at current levels between $70-75. Add on weakness as leadership remains intact with solid fundamentals.
Stock is appealing as it offers exposure in large cap Biotechnology.
STJ (St.Jude): Reaching a buy point at current levels. As a leader in the medical equipment group stock is cheap on a relative basis. Importantly, long-term technicals suggest adding on weakness.
Technology:
ORCL (Oracle): Relative strength is intact since summer 2006. Approaching major support at $19. Further declines enhance risk/reward for buyers. Company looks to benefit in a favorable M&A environment and upcoming quarter results.
AMAT (Applied Material): Recent expansion in the solar panel industry bodes well for long-term outlook. Stock is up 25% since early January 2008. Expect further upside move as fundamentals continue to improve.
Media:
DTV (Direct TV): Stabilizing at current levels between $22-24. Stock is attractive given increasing subscriber demand, international expansion and positive momentum.